InvestorsHub Logo
Followers 69
Posts 23313
Boards Moderated 4
Alias Born 02/23/2009

Re: TheFutureForsure post# 144120

Friday, 06/14/2019 11:17:56 AM

Friday, June 14, 2019 11:17:56 AM

Post# of 222472
Is Lowenthal reading his own disclosures ?

There were conversions just last february, as disclosed in the latest filing:

NOTE TO ISSUANCES:-
On February 2019 , shareholders representing an amount of 560,000 shares of Series “B” Convertible Preferred
Stock served Notices of Conversion to shares of Common Stock. This will increase in the amount of outstanding
Common Stock as was required to secure the majority shareholder vote to acquire the entire issued capital of
BioCann Pharma S.A.S. These conversions have not as yet been effected and it is envisaged that they will be in
and during May of 2019.



At a market price of 0.0001, 560 000 shares of Series B convert to 11.2 BILLION SHARES FOLKS or 5.6 BILLION if market price is 0.0002


And he dares to say NO CONVERSION ?

Welcome to the NEW TOXIC GNCP